scholarly journals 149P Real-world outcomes with first-line afatinib in EGFR mutant NSCLC adenocarcinoma: A single centre experience exploring effects of dose-reduction

2018 ◽  
Vol 13 (4) ◽  
pp. S89-S90 ◽  
Author(s):  
N. Tokaca ◽  
M. O'Brien ◽  
J. Bhosle ◽  
N. Yousaf ◽  
R. Kumar ◽  
...  
Keyword(s):  
Dose Reduction ◽  
Real World ◽  
First Line ◽  
Single Centre ◽  
Single Centre Experience ◽  
Egfr Mutant

Real world outcomes in patients with lung oligometastases treated with SABR – a single-centre experience

Lung Cancer ◽  
2021 ◽  
Vol 156 ◽  
pp. S58-S59
Author(s):  
Abiola Fatimilehin ◽  
Michelle Bewley ◽  
Sarah Bowen Jones ◽  
Clara Chan ◽  
Joanna Coote ◽  
...  
Keyword(s):  
Real World ◽  
Single Centre ◽  
Single Centre Experience

Real-world, single-centre experience of apremilast for the treatment of moderate to severe psoriasis

2017 ◽  
Vol 42 (6) ◽  
pp. 675-676 ◽  
Author(s):  
T. H. Wong ◽  
S. Sinclair ◽  
B. Smith ◽  
C. Fraser ◽  
C. A. Morton
Keyword(s):  
Real World ◽  
Severe Psoriasis ◽  
Single Centre ◽  
Single Centre Experience

First-line and beyond: West Midlands real-world data for EGFR mutant (EGFRm) NSCLC

Lung Cancer ◽  
2020 ◽  
Vol 139 ◽  
pp. S60-S61
Author(s):  
R. Powell ◽  
R. Kussaibati ◽  
A. Khan ◽  
A. Sivapalasuntharam ◽  
P. Wilson ◽  
...  
Keyword(s):  
Real World ◽  
First Line ◽  
Real World Data ◽  
World Data ◽  
West Midlands ◽  
Egfr Mutant

PFO closure with only fluoroscopic guidance: 7 years real-world single centre experience

2015 ◽  
Vol 86 (1) ◽  
pp. 105-112 ◽  
Author(s):  
Antonio Mangieri ◽  
Cosmo Godino ◽  
Matteo Montorfano ◽  
Francesco Arioli ◽  
Isabella Rosa ◽  
...  
Keyword(s):  
Real World ◽  
Fluoroscopic Guidance ◽  
Single Centre ◽  
Single Centre Experience ◽  
Pfo Closure
Sign in / Sign up

Export Citation Format

Share Document